FDA 483 - Misemer Pharmaceutical - February 23, 2026

Misemer Pharmaceutical, Inc. in Ripley, MS, was inspected regarding its role as an Own Label Distributor. The inspection revealed significant deficiencies in the timely submission of quarterly and annual adverse drug experience reports and annual reports for multiple drug products. Additionally, the firm lacked adequate written procedures for reporting postmarketing adverse drug experiences to the FDA.